Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.
Agoprene develops furniture foam from seaweed - completely free of petrochemicals.
Beech Biotech is utilizing cutting-edge biology to develop innovative therapies for preeclampsia and other pregnancy-related issues.
METSYSTEM has a unique technology that can predict cancer metastasis and determine the best chemotherapy to treat it preventively.
NorFalk is a biotech company that produces bio-based, sustainable surfactants for applications in consumer everyday products.
FÆRM is a food technology company.
Microminer is focused on developing innovative and sustainable technologies for extracting and recycling critical metals,
Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat antimicrobial resistance.
DARERL offers virtual human models for device development, providing digital anatomy based on real human bodies.
DIASENSE is creating a Quantum Diamond Magnetic Microscope that will be able to detect magnetic fields at high rates.
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly Parkinson's disease.
MedicQuant is a medical equipment manufacturing company developing diagnostic kits for blood anticoagulant properties.
Accelerating the cultured meat revolution
MELLO develops probiotic delivery technology to enhance the effective delivery of probiotics.
Probmet is a precision oncology therapeutics company developing treatments for cancer.
Aida uses machine learning and gene expression of individual tumors to help clinicians to prescribe the best drugs for each cancer patient.
Amplify Therapeutics is dedicated to the development of transformative, disease-modifying therapies for Gaucher disease.
Enduro Genetics is a technology provider committed to enabling large-scale fermentations.
SymbioMatch mission is to grow healthier plants using AI for tailored biostimulants with less fertilizers used.
Oasicare creates medical devices to help prevent severe perineal tears and OASI during vaginal childbirth.
SQALE offers precision fermentation and microalgae businesses Bioprocess Optimization as a service.
Polyceutix transforms cancer treatment by unleashing the full power of the immune system.
PreTT is revolutionizing the treatment of cancer by using sophisticated radioligand therapies that outperform conventional techniques.
Glaze Life Sciences is developing a non invasive device to monitor the blood glucose level.
BioInnovation Institute has invested in 141 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioInnovation Institute's top investment sectors include Biotechnology, Medical, Biopharma, Therapeutics, Health Care. The firm invests across 27 different industry categories.
Among tracked funding rounds, Enduro Genetics received $12.4M in a Series A round. BioInnovation Institute's total known invested capital is $314.9M.
BioInnovation Institute's average investment size is $4.0M across its portfolio of 141 companies.
Recent BioInnovation Institute portfolio additions include metaLead Therapeutics, Agoprene, Beech Biotech, METSYSTEM, NorFalk. These companies were founded in 2020 or later.